Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients

Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients

This phase I multicenter study was aimed at assessing the feasibility and safety of intravenous administration of third party bone marrow-derived mesenchymal stromal cells (MSC) expanded in platelet lysate in 40 patients (15 children and 25 adults), experiencing steroid-resistant grade II to IV graf...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Martino Introna, Giovanna Lucchini, Erica Dander, Stefania Galimberti, Attilio Rovelli, Adriana Balduzzi, Daniela Longoni, Fabio Pavan, Francesca Masciocchi, Alessandra Algarotti, Caterina Micò, Anna Grassi, Sara Deola, Irene Cavattoni, Giuseppe Gaipa, Daniela Belotti, Paolo Perseghin, Matteo Parma, Enrico Pogliani, Josée Golay, Olga Pedrini, Chiara Capelli, Sergio Cortelazzo, Giovanna D’Amico, Andrea Biondi, Alessandro Rambaldi, Ettore Biagi
Natura: Artigo
Lingua:inglese
Pubblicazione: 2013
Accesso online:https://doi.org/10.1016/j.bbmt.2013.11.033
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Accesso online

https://doi.org/10.1016/j.bbmt.2013.11.033

Documenti analoghi